What is CBC?

 CBC is short for cannabichromene or less commonly pentylcannabichromene. It’s one of roughly 140 similar chemical compounds present in varieties of cannabis, which include hemp and marijuana. CBC is the third-most abundant cannabinoid in cannabis, behind CBD and THC. 

As one of the “big six” most researched cannabinoids, CBC’s benefits are well-documented. CBC is good for pain, inflammation, acne, depression, and brain cell development, making it a promising cannabinoid for mental and physical ailments. 

As a general rule, CBC is best in combination with other cannabinoids such as CBD, THC, CBG, and other valuable plant compounds. While still a theory, plant compounds working together in synergy contribute to the entourage effect, a phenomenon where each compound’s effects and benefits are heightened in your body.

CBC’s activity at vanilloid receptor type 1 (TRPV1) and transient receptor potential ankyrin 1 (TRPA1) reduces pain and regulates pain perception, specifically in patients with cancer, fibromyalgia, and inflammatory bowel disease.

CBC could potentially fight signs of acne and skin inflammation on its own or paired with other cannabinoids. 

CBC has the most potent and effective antidepressant effects, much more than CBD and THC, and on par with pharma-based antidepressant drugs. 

CBC effects are relaxing and mood-lifting with the ability to reduce pain and regulate pain perception. CBC’s effects are complemented by the soothing anti-anxiety qualities of CBD, CBG, and THC.